Rainier Rehab Logo
Editorial illustration of a corridor of gate frames with blocks clustered at the entrance and only…
November 19, 20268 min read

Half of Wisconsin's Treatment Court Participants Never Graduate. The Funnel Narrows Before They Arrive.

A treatment court is a promise with a courtroom attached. Complete the program and the charge goes away, or comes back lighter. Fail, and the case resumes its ordinary path toward a conviction, a sentence, and in Wisconsin often a cell.

The Wisconsin Policy Forum spent months counting how often that promise is kept. Its review, commissioned by the global health nonprofit Vital Strategies and presented to reporters on Tuesday, covers all 104 treatment courts operating in the state — drug courts, OWI courts, veterans courts, wellness courts — and pulls detailed data from the 61 that receive Treatment Alternatives and Diversion funding, the state grants that require each court to report outcomes. Coordinators at 53 courts in 43 counties answered the survey behind it.

The headline number is 54 percent. That is the share of people admitted to TAD-funded treatment courts between 2019 and 2024 who graduated. The national benchmark the report uses, from the National Treatment Court Resource Center, is 60.7 percent.

Jason Stein, the forum's president, anticipated the obvious misreading. "Sometimes there's a misconception that treatment court is easy or that it doesn't ask a lot of participants," he said, "and you can see here that the data tell a different story, in terms of who makes it through to the end."

The funnel narrows in three places, not one

Graduation rates get quoted as if they describe a single moment of failure. The report's data describe a sequence, and the share of white participants grows at every step of it.

Of everyone referred to a TAD treatment court, 82 percent were white, 7.6 percent were Black and 6.9 percent were Native American. By the time referrals clear eligibility screening and are admitted, the white share has expanded. By graduation it has expanded again: white participants were 90.9 percent of all graduates over the five-year window.

The arithmetic the report leaves out

The report also gives a white completion rate of 56.8 percent against the 54 percent overall figure. Those two numbers, read together, produce an estimate the report itself does not print: if white participants were 90.9 percent of graduates and finished at 56.8 percent, they were roughly 86 percent of admissions — which puts completion for everyone else at about 36 percent. That is a derived figure, not a published one, and it rests on the two rates sharing the same denominator. But the direction is not in doubt, and it is the direction that matters for anyone deciding where to intervene.

"These disparate outcomes make this an important area for policymakers, treatment court teams and the general public to keep track of," Stein said. The report does not explain them. It cannot: the data show who moved through the funnel, not why the gate narrowed. Everything from eligibility criteria that hinge on charged offense, to transportation and childcare, to the demographics of who gets a public defender willing to argue for diversion, sits inside that unexplained gap.

Jail is the sanction in 60 of 61 courts

Sixty of the 61 TAD courts reported using jail as a sanction for participants. Ten of 45 survey respondents — one in five — said they use short-term jail in response to a positive drug test alone, and 29 percent said recurring use is a reason to terminate participation. Termination returns a person to an ordinary criminal docket.

Adrienne Hurst of Vital Strategies put the clinical problem plainly at the press conference: "Punishment for drug use is not treatment." The report's review of court manuals found more than 20 percent describe jail-based sanctions for a positive urine test, and a subset apply jail when a participant denied use but the test came back positive — an honesty penalty layered on top of a drug penalty.

What a night in jail costs clinically

Stein flagged the part that rarely makes it into program brochures. "Individuals when released from jail are at a heightened risk of an overdose," he said. Jail as a sanction is not a neutral pause in treatment; it interrupts tolerance, severs the connection to a prescriber, and returns people to the community at the moment their opioid tolerance is lowest. The All Rise Adult Drug Court Best Practice Standards — the field's own reference document — say jail should be used to protect public safety, not as a response to substance use. Wisconsin's courts are, in the aggregate, doing something the standards advise against.

Medication is allowed almost everywhere. The choice still gets made by someone.

Most responding courts allow methadone and buprenorphine, which Hurst described as "the standards for treatment for opioid use disorder." She drew the distinction that matters clinically: naltrexone is FDA-approved but "significantly less protective against overdose than buprenorphine and methadone." Her recommendation was that medication choice belong to the participant and a medical provider, and that it require "the availability of all options."

For families reading a court contract, that sentence is the practical test. A court that permits buprenorphine in principle but has no prescriber relationship cannot actually deliver it. A court that permits methadone but schedules obligations that conflict with daily dosing hours has permitted it on paper only. For people navigating medication-assisted treatment, the standard to ask about is not whether a medication is allowed but who prescribes it, where it is dispensed, and whether the court's own schedule can accommodate it.

A system that shrank while the need did not

Drug and narcotics violations accounted for nearly a quarter of arrests in Wisconsin in 2023, according to the report — roughly the population these courts exist to divert. Yet 26 of the 40 coordinators who answered the question said their courts hold fewer people today than in 2019. Eleven said they hold more.

That divergence is the quiet finding. A program can post a respectable graduation rate while serving half as many people, and the rate will look like success. Nothing in the report suggests the courts are turning people away by choice; the survey did not isolate a cause. But a shrinking caseload in a state where arrests for drug offenses have not shrunk proportionally is a capacity question that the outcomes data cannot answer.

The exclusion nobody prices in

Forty-one percent of survey respondents said their courts exclude people who sell drugs. Hurst's objection was economic rather than moral: "Low-level drug sales is a common form of survival economics for people with substance use disorder," she said, "and the exclusion of these offenses is a missed opportunity to support individuals who could benefit from the treatment court model."

That exclusion interacts with the racial funnel in a way the report does not model. If the offenses that disqualify someone are distributed unevenly across neighborhoods — and drug-sales charges generally are — then a rule written as neutral can widen a gap that no one intended.

What the report asks for

Vital Strategies' recommendations are the familiar set, delivered with unusually specific targets. Defer prosecution rather than requiring a conviction or guilty plea as the price of entry, since a record itself obstructs recovery. Stop treating predictable setbacks as grounds for removal. Evaluate courts for fidelity to best practice without larding on requirements that "increase the intensity of court requirements on participants." Review fines and fees so they do not become a participation barrier. Take the highest-risk candidates, whom the research says benefit most from intensive programs.

The report does not recommend abolishing jail sanctions, and it does not estimate a cost for the changes it proposes. It also does not answer the question a family in the gallery would ask: what happens to the 46 percent who do not graduate, and whether the treatment they received inside the program outlasts the termination.

What it does is put a number on a promise. In Wisconsin, roughly half the people who enter a treatment court leave it with the outcome the court was designed to produce. The other half leave with a criminal case, a jail sanction on the record, and — the report's own warning — a heightened overdose risk at exactly the moment supervision ends. For anyone weighing levels of care for themselves or a family member, that is the honest arithmetic to bring into the room: the program is not a guarantee, and the exit is not neutral.

Judge Carl Ashley of Milwaukee County Circuit Court, speaking at the same briefing, offered the version of the argument that the data cannot carry. "Treatment court is the hardest thing participants have ever done," he said. "What they also get for the first time in their lives is a team that believes they can change." Whether that team should be holding a jail cell over someone's head is precisely the question the report leaves with the legislature.

RR
Rainier Rehab Editorial Team

Editorial Board

LADC, LCPC, CASAC

The Rainier Rehab editorial team consists of licensed addiction counselors, healthcare journalists, and recovery advocates dedicated to providing accurate, evidence-based information about substance abuse treatment and rehabilitation.

Related Articles